Posted inEmerging Market
Bitcoin Holds Strong Above $81000 Driven by Heavy ETF Inflows
Discover the latest cryptocurrency market updates as Bitcoin maintains its position above $81000 amid significant ETF inflows on September 4, 2026.
Posted inMarket
Mizuho Increases UiPath Price Target to 14 Dollars Following Robust Earnings
Mizuho raises UiPath stock price target to 14 dollars following strong financial results and solid business performance in the software sector.
Posted inMarket
Canaccord Reaffirms Zscaler Stock Rating Amid Sales Force Transition
Canaccord Genuity maintains its current investment rating for Zscaler as the cloud security firm navigates a major sales force reorganization.
Posted inMarket
Legend Biotech Stock Maintained at Buy by H.C. Wainwright
H.C. Wainwright maintains its buy rating for Legend Biotech, highlighting strong market positioning and ongoing growth potential.
Posted inCorporate Updates
Bitcoin and Ethereum: Five Key Steps for Investors to Navigate the Next Phase
Bitcoin and Ethereum have entered October with a broadly stable market structure, but neither has confirmed a decisive breakout. Bitcoin traded between approximately USD83,020 and USD83,775 during the period before…
Posted inCorporate Updates
Smile Train India Brings Smile Walls to Communities Across the Country for World Smile Day
Smile Train, the world’s largest cleft-focused organization, celebrated World Smile Day with its partner hospitals and communities across the country, inviting people to share what makes them smile and help raise…
Posted inCorporate Updates
Oxford University Press and Canva Join Hands to Empower Future-Ready Learners
In a significant step towards building future-ready classrooms, Oxford University Press (OUP), a leading education publisher with a longstanding commitment to advancing learning, today announced a strategic collaboration with Canva,…
Posted inMarket
H.C. Wainwright Reaffirms Ionis Stock Rating Following Zanvastro Approval
H.C. Wainwright maintains its stock rating for Ionis Pharmaceuticals following the regulatory approval of Zanvastro, highlighting market confidence.
Posted inMarket
H.C. Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals Following Regulatory Nod in China
H.C. Wainwright maintains its Buy rating for Milestone Pharmaceuticals following a significant regulatory approval in China.
Posted inMarket
Why Stock Market Selloff Risks Are Growing and How Investors Should Respond
Discover why financial experts warn that stock market selloff risks are increasing and learn strategic steps to protect your investment portfolio today.
